Six years experience using inhalatory interleukin-2 in pulmonary metastatic renal cell carcinoma

被引：0
|
作者：
Huland, E [1 ]
Heinzer, H [1 ]
Huland, H [1 ]
机构：
[1] UNIV HAMBURG,CLIN EPPENDORF,DEPT UROL,HAMBURG,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：373 / 373
页数：1
相关论文
共 50 条
  • [21] The application of high-dose interleukin-2 for metastatic renal cell carcinoma
    David F. McDermott
    Medical Oncology, 2009, 26 : 13 - 17
  • [22] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Johannes Vieweg
    Nature Clinical Practice Oncology, 2005, 2 : 192 - 193
  • [23] Can outpatient interleukin-2 and interferon replace high-dose interleukin-2 for metastatic renal cell carcinoma?
    Vieweg, J
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (04): : 192 - 193
  • [24] HIGH-DOSE INTERLEUKIN-2 IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA AND MELANOMA: A CONTEMPORARY LOUISIANA EXPERIENCE
    Kwan, Nathan
    Patel, Charmi
    Miletello, Gerald P.
    Brantley, Paula Rhode
    ANTICANCER RESEARCH, 2015, 35 (12) : 6702 - 6702
  • [25] OUTCOME OF HIGH-DOSE INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL CELL CARCINOMA: SINGLE INSTITUTION EXPERIENCE
    Dudek, A. Z.
    Yee, H. O.
    Yee, R. T.
    Chereddy, S.
    Manivel, J. C.
    ANNALS OF ONCOLOGY, 2008, 19 : 196 - 197
  • [26] Subcutaneous interleukin-2 and interferon-α in metastatic renal cell carcinoma -: Results of a French regional experience in Languedoc
    Culine, S
    Iborra, F
    Mottet, N
    Avancès, C
    de Graeve, B
    Volpé, P
    Vignoud, J
    Bringer, JP
    Marroncle, M
    Le Pellec, L
    Ayuso, D
    Jansen, E
    Faix, A
    Rebillard, X
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2006, 29 (02): : 148 - 152
  • [27] Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma
    Schrader, AJ
    Heidenreich, A
    Hegele, A
    Olbert, P
    Ohlmann, CH
    Varga, Z
    von Knobloch, R
    Hofmann, R
    ANTI-CANCER DRUGS, 2005, 16 (05) : 581 - 585
  • [28] HIGH-DOSE INTERLEUKIN-2 IN THE THERAPY OF METASTATIC RENAL-CELL CARCINOMA
    PARKINSON, DR
    SZNOL, M
    SEMINARS IN ONCOLOGY, 1995, 22 (01) : 61 - 66
  • [29] Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma
    Olencki, T
    Malhi, S
    Mekhail, T
    Dreicer, R
    Elson, P
    Wood, L
    Bukowski, RM
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (04) : 321 - 326
  • [30] Phase I trial of thalidomide and Interleukin-2 in patients with metastatic renal cell carcinoma
    Thomas Olencki
    Sareena Malhi
    Tarek Mekhail
    Robert Dreicer
    Paul Elson
    Laura Wood
    Ronald M. Bukowski
    Investigational New Drugs, 2006, 24 : 321 - 326
12345